1. Home
  2. GXO vs GRFS Comparison

GXO vs GRFS Comparison

Compare GXO & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GXO
  • GRFS
  • Stock Information
  • Founded
  • GXO 2021
  • GRFS 1940
  • Country
  • GXO United States
  • GRFS Spain
  • Employees
  • GXO N/A
  • GRFS N/A
  • Industry
  • GXO Transportation Services
  • GRFS Biotechnology: Pharmaceutical Preparations
  • Sector
  • GXO Consumer Discretionary
  • GRFS Health Care
  • Exchange
  • GXO Nasdaq
  • GRFS Nasdaq
  • Market Cap
  • GXO 4.8B
  • GRFS 7.2B
  • IPO Year
  • GXO N/A
  • GRFS 2006
  • Fundamental
  • Price
  • GXO $51.12
  • GRFS $9.82
  • Analyst Decision
  • GXO Buy
  • GRFS Hold
  • Analyst Count
  • GXO 13
  • GRFS 1
  • Target Price
  • GXO $60.62
  • GRFS $10.30
  • AVG Volume (30 Days)
  • GXO 852.8K
  • GRFS 507.4K
  • Earning Date
  • GXO 11-03-2025
  • GRFS 07-28-2022
  • Dividend Yield
  • GXO N/A
  • GRFS 1.46%
  • EPS Growth
  • GXO N/A
  • GRFS 132.60
  • EPS
  • GXO 0.53
  • GRFS 0.53
  • Revenue
  • GXO $12,683,000,000.00
  • GRFS $8,744,226,659.00
  • Revenue This Year
  • GXO $13.55
  • GRFS $5.61
  • Revenue Next Year
  • GXO $6.51
  • GRFS $6.70
  • P/E Ratio
  • GXO $95.62
  • GRFS $24.59
  • Revenue Growth
  • GXO 22.39
  • GRFS 9.32
  • 52 Week Low
  • GXO $30.46
  • GRFS $6.19
  • 52 Week High
  • GXO $63.33
  • GRFS $11.14
  • Technical
  • Relative Strength Index (RSI)
  • GXO 48.26
  • GRFS 46.43
  • Support Level
  • GXO $50.08
  • GRFS $9.63
  • Resistance Level
  • GXO $52.09
  • GRFS $10.06
  • Average True Range (ATR)
  • GXO 1.24
  • GRFS 0.19
  • MACD
  • GXO -0.21
  • GRFS -0.02
  • Stochastic Oscillator
  • GXO 34.78
  • GRFS 38.46

About GXO GXO Logistics Inc.

GXO Logistics Inc is a contract logistics company. Its revenue is diversified across numerous verticals and customers, including many multinational corporations. It provides warehousing and distribution, order fulfillment, e-commerce, reverse logistics, and other supply chain services differentiated by its ability to deliver technology-enabled, customized solutions at scale. Geographically, it generates revenue from the United Kingdom, the United States, the Netherlands, France, Spain, Italy, and other countries, and derives the majority of its revenue from the United Kingdom.

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

Share on Social Networks: